Top compounds associated with response to MT-ND4L


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.04
mRNA spautin-1 CTRPv2 pan-cancer AAC 0.089 0.04
mRNA PD318088 CTRPv2 pan-cancer AAC 0.083 0.04
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.04
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.066 0.04
mRNA Compound 1541A CTRPv2 pan-cancer AAC -0.088 0.05
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.078 0.05
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.05
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.05
mRNA tivozanib CTRPv2 pan-cancer AAC -0.081 0.05
Download CSV